$
2.210
-0.23(-9.426%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.380
Open
2.370
VWAP
2.30
Vol
242.50K
Mkt Cap
3.60M
Low
2.190
Amount
557.90K
EV/EBITDA(TTM)
--
Total Shares
3.25M
EV
3.54M
EV/OCF(TTM)
--
P/S(TTM)
--
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Show More
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for Scisparc Ltd (SPRC.O) is 0.00, compared to its 5-year average forward P/E of -12.34. For a more detailed relative valuation and DCF analysis to assess Scisparc Ltd 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-12.34
Current PE
0.00
Overvalued PE
26.51
Undervalued PE
-51.20

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.53
Current PS
0.05
Overvalued PS
4.69
Undervalued PS
-1.63
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
AI Stock Picker

SPRC News & Events

Events Timeline

2025-08-28 (ET)
2025-08-28
07:13:55
SciSparc Shareholders Give Green Light to Merger with AutoMax Motors
select
2025-08-07 (ET)
2025-08-07
08:20:14
SciSparc-Clearmind collab leads to international patent application
select
2025-08-07
08:02:08
Clearmind announces publication of international patent application under PCT
select
Sign Up For More Events

News

8.5
08-28Newsfilter
SciSparc: AutoMax Shareholders Give Green Light to Merger with SciSparc
8.5
08-28NASDAQ.COM
SciSparc Shareholders Greenlight Merger with Israel's AutoMax Motors
3.5
08-07Newsfilter
SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
Sign Up For More News

FAQ

arrow icon

What is Scisparc Ltd (SPRC) stock price today?

The current price of SPRC is 2.21 USD — it has decreased -9.43 % in the last trading day.

arrow icon

What is Scisparc Ltd (SPRC)'s business?

arrow icon

What is the price predicton of SPRC Stock?

arrow icon

What is Scisparc Ltd (SPRC)'s revenue for the last quarter?

arrow icon

What is Scisparc Ltd (SPRC)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Scisparc Ltd (SPRC)'s fundamentals?

arrow icon

How many employees does Scisparc Ltd (SPRC). have?

arrow icon

What is Scisparc Ltd (SPRC) market cap?